AbbVie's Options: A Look at What the Big Money Is Thinking
AbbVie's Options: A Look at What the Big Money Is Thinking
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $195.0 for AbbVie over the recent three months. Deep-pocketed investors have adopted a bullish approach towards AbbVie (NYSE:ABBV), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ABBV usually suggests something big is about to happen.
資金充沛的投資者對摩根士丹利表現出看好態勢，市場參與者不應忽略這一點。我們在Benzinga跟蹤公共期權記錄的過程中揭示了這次重大變動。這些投資者的身份仍未公開，但在ABBV股票通常出現如此大幅變動時，這通常意味着即將出現重要事件。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for AbbVie. This level of activity is out of the ordinary.
我們從今天的觀察中獲得了這些信息，當Benzinga的期權掃描器突出顯示AbbVie的8種非凡的期權交易活動。這種活動水平是不同尋常的。
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 2 are puts, totaling $109,500, and 6 are calls, amounting to $402,314.
這些重量級投資者的普遍情緒有分歧，50%看好，50%看淡。在這些顯著的期權中，有2個看跌，總額爲109,500美元，有6個看漲，總額爲402,314美元。
Expected Price Movements
預期價格波動
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $195.0 for AbbVie over the recent three months.
根據交易活動，顯然主要投資者的目標價格區間爲艾伯維公司在最近三個月內的150.0至195.0美元。
Volume & Open Interest Development
成交量和持倉量的評估是期權交易中的一個關鍵步驟。這些指標揭示了阿里巴巴集團（Alibaba Gr Hldgs）特定執行價格期權的流動性和投資者興趣。下面的數據可視化了在過去30天內，阿里巴巴集團（Alibaba Gr Hldgs）在執行價格在74.0美元到120.0美元區間內的看漲看跌期權中，成交量和持倉量的波動情況。
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in AbbVie's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to AbbVie's substantial trades, within a strike price spectrum from $150.0 to $195.0 over the preceding 30 days.
評估成交量和持倉量是期權交易中的戰略步驟。這些指標揭示了對艾伯維公司期權在特定執行價格的流動性和投資者興趣。即將到來的數據可視化顯示了過去30天內關於看漲和看跌的成交量和持倉量的波動，與艾伯維公司的大宗交易相對應，在150.0至195.0美元的執行價格範圍內。
AbbVie Call and Put Volume: 30-Day Overview
艾伯維公司看漲和看跌成交量：30天總覽
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | TRADE | BEARISH | 11/15/24 | $14.95 | $14.65 | $14.65 | $180.00 | $99.6K | 1.6K | 69 |
| ABBV | CALL | TRADE | BULLISH | 10/11/24 | $12.85 | $12.05 | $12.61 | $180.00 | $87.0K | 76 | 69 |
| ABBV | CALL | TRADE | BEARISH | 01/16/26 | $28.2 | $27.9 | $27.9 | $180.00 | $80.9K | 408 | 29 |
| ABBV | PUT | TRADE | BEARISH | 02/21/25 | $11.45 | $10.1 | $11.45 | $195.00 | $68.7K | 598 | 0 |
| ABBV | CALL | SWEEP | BULLISH | 11/15/24 | $5.75 | $5.65 | $5.75 | $195.00 | $63.8K | 3.0K | 200 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 艾伯維公司 | 看漲 | 交易 | 看淡 | 11/15/24 | $14.95 | $14.65 | $14.65 | 180.00美元 | $99.6K | 1.6K | 69 |
| 艾伯維公司 | 看漲 | 交易 | 看好 | 10/11/24 | $12.85 | $12.05 | $12.61 | 180.00美元 | $87.0K | 76 | 69 |
| 艾伯維公司 | 看漲 | 交易 | 看淡 | 01/16/26 | $28.2 | $27.9 | $27.9 | 180.00美元 | $80.9K | 408 | 29 |
| 艾伯維公司 | 看跌 | 交易 | 看淡 | 02/21/25 | $11.45 | $10.1 | $11.45 | $195.00 | $68.7K | 598 | 0 |
| 艾伯維公司 | 看漲 | SWEEP | 看好 | 11/15/24 | $5.75 | $5.65 | $5.75 | $195.00 | $63.8K應該是指成交量爲63,800股。 | 3.0K | 200 |
About AbbVie
關於艾伯維公司
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
AbbVie是一家藥品公司，其在免疫學（包括Humira、Skyrizi和Rinvoq）和腫瘤學（包括Imbruvica和Venclexta）方面擁有強大的業務。該公司於2013年初從Abbott分拆而來。2020年收購雅培使其在美容業務（包括Botox）中新增了一些產品和藥品。
Having examined the options trading patterns of AbbVie, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
在審查AbbVie的期權交易模式後，我們的注意力現在直接轉向該公司。這種轉變使我們能夠深入探討其現在的市場地位和表現。
Where Is AbbVie Standing Right Now?
艾伯維目前處於什麼狀態？
- Trading volume stands at 729,519, with ABBV's price up by 0.12%, positioned at $193.25.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 21 days.
- 成交量爲729,519，艾伯維公司的股價上漲0.12%，定位在193.25美元。
- RSI指標顯示該股票目前處於超買和超賣之間的中立狀態。
- 業績預計在21天內公佈。
Professional Analyst Ratings for AbbVie
AbbVie的專業分析師評級
2 market experts have recently issued ratings for this stock, with a consensus target price of $218.5.
最近，兩位市場專家爲這支股票發佈了評級，一致目標價爲218.5美元。
Turn $1000 into $1270 in just 20 days?
在短短20天內，將1000美元變成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* Consistent in their evaluation, an analyst from TD Cowen keeps a Buy rating on AbbVie with a target price of $225. * Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for AbbVie, targeting a price of $212.
20年期期權交易專家揭示了他的一行圖表技術，顯示何時買入和賣出。跟隨他的交易，平均每20天獲利27%。點擊這裏查看。* 在評估方面保持一貫性，TD Cowen的分析師繼續對艾伯維公司給予買入評級，目標價225美元。* 保持立場，巴克萊銀行的分析師繼續持有對艾伯維公司的超配評級，目標價212美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。
